Switch View
© BusinessWire
25.09.2025
ISIN: US4718712023
Jasper Therapeutics, Inc.
JSPR
LISTED
NASDAQ
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Encourages Jasper Therapeutics, Inc. (JSPR) Shareholders To Inquire About Securities Fraud Class Action
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Jasper Therapeutics, Inc. (“Jasper” or the “Company”) (NASDAQ: JSPR) securities between November 30, 2023 and July 3, 2025, inclusive (the...
Themefolio
Profiler
Peergroup
© ActuNews
25.09.2025
ISIN: FR0013286259
Theranexus SA
ALTHX
LISTED
EURONEXT
THERANEXUS ANNONCE SES RÉSULTATS FINANCIERS DU PREMIER SEMESTRE 2025
News Preview
Lyon, France – 25 septembre 2025 – 18h CEST – Theranexus, société biopharmaceutique innovante dans le traitement des maladies neurologiques rares, publie aujourd'hui ses résultats semestriels au 30 juin 2025.
Mathieu Charvériat, Président directeur général de Theranexus, d&eacut...
Themefolio
Profiler
Peergroup
© ActuNews
25.09.2025
ISIN: FR0013286259
Theranexus SA
ALTHX
LISTED
EURONEXT
THERANEXUS ANNOUNCES FIRST HALF 2025 FINANCIAL RESULTS
News Preview
THERANEXUS ANNOUNCES FIRST HALF 2025 FINANCIAL RESULTS
Lyon, France – 25 September 2025 – 6pm CEST – Theranexus, a biopharmaceutical company innovating in the treatment of rare neurological diseases, today publishes its first half results as of 30 June 2025.
Mathieu Charvériat, Chairman and CEO of Theranexus, comments: &ldq...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
25.09.2025
ISIN: US16359R1032
Chemed Corp
CHE
LISTED
NYSE
VITAS® Healthcare, Leading Hospice Provider, Named a 2025 Top Workplace in Healthcare by Top Workplaces USA
News Preview
MIRAMAR, Fla., Sept. 25, 2025 /PRNewswire/ -- VITAS Healthcare, the nation's leading provider of end-of-life care, has been named a 2025 Top Workplace in Healthcare by Top Workplaces USA, a national program that honors organizations based solely on employee feedback. VITAS is one of only 57 healthcare organizations nationwide with more than 1,000...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
25.09.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Nutex Health Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – NUTX
News Preview
The DJS Law Group reminds investors of a class action lawsuit against Nutex Health Inc. (“Nutex” or “the Company”) (NASDAQ: NUTX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of NUTX during the cla...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Sunshine Health Awards Over $100,000 in Grants to Strengthen Florida Communities
News Preview
FORT LAUDERDALE. Fla., Sept. 25, 2025 /PRNewswire/ -- Sunshine Health, a company of Centene Corporation (NYSE: CNC), has awarded $106,000 in "Get to Know Us" grants to 50 nonprofit organizations across Florida that deliver vital programs addressing health-related social needs....
Themefolio
Profiler
Peergroup
© ACCESSWIRE
25.09.2025
ISIN: US18507C1036
Clearpoint Neuro Inc
CLPT
LISTED
NASDAQ
ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer
News Preview
SOLANA BEACH, CALIFORNIA / ACCESS Newswire / September 25, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that Dr. Paul Larson will be joining the company as Chief Medical Officer starting in January 2...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
25.09.2025
ISIN: US83558L2043
Sonoma Pharmaceuticals, Inc.
SNOA
LISTED
NASDAQ
Sonoma Pharmaceuticals to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
News Preview
BOULDER, COLORADO / ACCESS Newswire / September 25, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, dermatological conditions, podiatry, and an...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: DE000BAY0017
Bayer AG
BAYN
LISTED
XETR
Bayer Canada Announces New Distribution Partnership for ADALAT® XL® (nifedipine extended-release tablets) 30 mg Tablets in Canada
News Preview
Bayer Canada is pleased to announce a new partnership with Mint Pharmaceuticals Inc. for the distribution of ADALAT® XL® 30 mg tablets1 in Canada. This strategic collaboration took effect on September 3, 2025.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250925537941/en/From Left to...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: FR0012127173
OSE Immunotherapeutics SA
OSE
LISTED
EURONEXT
OSE Immunotherapeutics publie sa position de trésorerie au 30 juin 2025
News Preview
OSE Immunotherapeutics Reports its Cash Position as of June 30, 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US74834L1008
Quest Diagnostics Inc
DGX
LISTED
NYSE
Quest Diagnostics to Release Third Quarter 2025 Financial Results on October 21, 2025
News Preview
SECAUCUS, N.J., Sept. 25, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, today announced that it will report third quarter 2025 financial results on Tuesday, October 21, 2025, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US4448591028
Humana Inc
HUM
LISTED
NYSE
Healthcare Innovation Accelerates as Four Converging Forces Drive Early Intervention Focus
News Preview
USA News Group News Commentary
Issued on behalf of Avant Technologies Inc.
VANCOUVER, BC, Sept. 25, 2025 /CNW/ -- America's aging demographics are creating unprecedented demand for precision healthcare solutions, with population projections showing nearly one in four Americans will be over 65 by 2060[1]. Gene therapy approvals continue accelerati...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
25.09.2025
ISIN: US4448591028
Humana Inc
HUM
LISTED
NYSE
Healthcare Innovation Accelerates as Four Converging Forces Drive Early Intervention Focus
News Preview
USA News Group News Commentary
Issued on behalf of Avant Technologies Inc.
VANCOUVER, BC, Sept. 25, 2025 /PRNewswire/ -- America's aging demographics are creating unprecedented demand for precision healthcare solutions, with population projections showing nearly one in four Americans will be over 65 by 2060[1]. Gene therapy approvals continue acc...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US4448591028
Humana Inc
HUM
LISTED
NYSE
Healthcare Innovation Accelerates as Four Converging Forces Drive Early Intervention Focus
News Preview
USA News Group News Commentary
Issued on behalf of Avant Technologies Inc.
VANCOUVER, BC, Sept. 25, 2025 /PRNewswire/ -- America's aging demographics are creating unprecedented demand for precision healthcare solutions, with population projections showing nearly one in four Americans will be over 65 by 2060[1]. Gene therapy approvals continue acc...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: US36266G1076
GE Healthcare Technologies Inc
GEHC
LISTED
NASDAQ
GE HealthCare debuts AI-supported solution, designed to improve and shorten the radiation therapy workflow, at ASTRO 2025
News Preview
GE HealthCare (Nasdaq: GEHC) today announced updates to Intelligent Radiation Therapy (iRT), a new version of the company’s software solution for radiation therapy workflow management, designed to reduce the time it takes for patients to go from diagnosis to treatment. The iRT solution is AI-supported by GE HealthCare and third-party applications,...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US2197981051
QuidelOrtho Corp
QDEL
LISTED
NASDAQ
Through Shades of Illness: Science Bytes Podcast Discusses Why Testing Matters
News Preview
SAN DIEGO, Sept. 25, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader of in vitro diagnostics, has released the latest episode of its Science Bytes podcast, featuring Dr. Terry O'Neil, President and Medical Director of Urgent Care Pros....
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US02155H1014
Altimmune, Inc.
ALT
LISTED
NASDAQ
Investors in Altimmune, Inc. Should Contact The Gross Law Firm Before October 6, 2025 to Discuss Your Rights - ALT
News Preview
NEW YORK, Sept. 25, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Altimmune, Inc. (NASDAQ: ALT).
Shareholders who purchased shares of ALT during the class period listed are encouraged to con...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of November 10, 2025 in Lantheus Lawsuit - LNTH
News Preview
NEW YORK, Sept. 25, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Lantheus Holdings, Inc. (NASDAQ: LNTH).
Shareholders who purchased shares of LNTH during the class period listed are encoura...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Shareholders that lost money on Cytokinetics, Incorporated(CYTK) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
News Preview
NEW YORK, Sept. 25, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cytokinetics, Incorporated (NASDAQ: CYTK).
Shareholders who purchased shares of CYTK during the class period listed are enco...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Lost Money on Savara Inc.(SVRA)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
News Preview
NEW YORK, Sept. 25, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Savara Inc. (NASDAQ: SVRA).
Shareholders who purchased shares of SVRA during the class period listed are encouraged to conta...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
Shareholders that lost money on Semler Scientific, Inc.(SMLR) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
News Preview
NEW YORK, Sept. 25, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Semler Scientific, Inc. (NASDAQ: SMLR).
Shareholders who purchased shares of SMLR during the class period listed are encoura...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
October 21, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against NUTX
News Preview
NEW YORK, Sept. 25, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nutex Health Inc. (NASDAQ: NUTX).
Shareholders who purchased shares of NUTX during the class period listed are encouraged to...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
Shareholders that lost money on LifeMD, Inc.(LFMD) should contact The Gross Law Firm about pending Class Action - LFMD
News Preview
NEW YORK, Sept. 25, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of LifeMD, Inc. (NASDAQ: LFMD).
Shareholders who purchased shares of LFMD during the class period listed are encouraged to cont...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US45773H4092
Inovio Pharmaceuticals Inc
INO
LISTED
NASDAQ
INOVIO to Participate in Upcoming Scientific Conferences
News Preview
Several presentations to highlight key aspects of lead product candidate, INO-3107, as a potential treatment for Recurrent Respiratory Papillomatosis (RRP)Additional presentations focus on promise of next-generation DNA medicine technology, including the first preclinical data describing potential for DNA-encoded protein technology (DPROT) to add...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US54948X1090
Lucid Diagnostics Inc.
LUCD
LISTED
NASDAQ
Lucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of Directors
News Preview
Growth-focused healthcare executive brings 40 years of executive leadership experience across multiple industry sectors
NEW YORK, Sept. 25, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today ann...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: US75120L1008
Rallybio Corp
RLYB
LISTED
NASDAQ
Rallybio Completes Dosing of First Cohort in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study
News Preview
Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company translating scientific advances into transformative therapies for patients with devastating rare diseases, today announced the completion of dosing of the first cohort in the Phase 1 confirmatory pharmacokinetic/pharmacodynamic (PK/PD) study evaluating RLYB116, the Company...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: US3755581036
Gilead Sciences Inc
GILD
LISTED
NASDAQ
Gilead Foundation Grants $6.5 Million in Commitment to STEM Education
News Preview
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that it has committed more than $6.5 million in grant funding toward strengthening science, technology, engineering and math (STEM) education pathways in the San Francisco Bay Area and beyond. The funding, distributed through the Gilead Foundation, will build on the company’s ongoing work to cul...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: US81663L2007
GeneDx Holdings Corp
WGS
LISTED
NASDAQ
GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference
News Preview
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it will introduce pediatricians to GeneDx’s Infinity, the company’s proprietary dataset, at the American Academy of Pediatrics (AAP) National Conference & Exhibition taking place this weekend September 26 to 30 in Denver, CO. Infinit...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: DE000BAY0017
Bayer AG
BAYN
LISTED
XETR
Bayer to Highlight New Data for KERENDIA® (finerenone) at Heart Failure Society of America (HFSA) Annual Scientific Meeting 2025
News Preview
Bayer announced today that data from across the KERENDIA® (finerenone) comprehensive clinical trial program will be presented at the Heart Failure Society of America (HFSA)’s Annual Scientific Meeting in Minneapolis, Minnesota, September 26-29, 2025.
In July 2025, the U.S. Food and Drug Administration (FDA) approved a new indication for KERENDIA...
Themefolio
Profiler
Peergroup
© Newsfile
25.09.2025
ISIN: US29415V1098
Envoy Medical, Inc.
COCH
LISTED
NASDAQ
Envoy Medical Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
News Preview
White Bear Lake, Minnesota--(Newsfile Corp. - September 25, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company focused on developing innovative, fully implanted hearing solutions, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules of 1,9...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US9216591084
Vanda Pharmaceuticals Inc
VNDA
LISTED
NASDAQ
Vanda Pharmaceuticals announces the publication in PLOS One of an article titled "Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trial"
News Preview
WASHINGTON, Sept. 25, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the publication of an article titled "Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trial" in PLOS One, a leading open-access journal....
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US45826J1051
Intellia Therapeutics Inc
NTLA
LISTED
NASDAQ
Intellia Therapeutics Announces Positive Longer-Term Phase 1 Data for Nexiguran Ziclumeran (nex-z) in Patients with Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy
News Preview
CAMBRIDGE, Mass., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced longer-term follow-up data from the ongoing Phase 1 study of investigational nexiguran ziclumeran (nex-z) for the treatment o...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: US92532F1003
Vertex Pharmaceuticals Inc
VRTX
LISTED
NASDAQ
Vertex Announces Key Advancements Across Kidney Portfolio
News Preview
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important advancements across its programs in immunoglobulin A Nephropathy (IgAN), APOL1-mediated kidney disease (AMKD) and autosomal dominant polycystic kidney disease (ADPKD). These updates represent significant progress toward reaching the Company’s goal of bringing forw...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: KYG970081173
WuXi Biologics (Cayman) Inc
2269
LISTED
HKSE
WuXi Biologics Launches WuXia™4.0, Targeted Integration Cell Line Platform TrueSite TI™，to Accelerate Biologics Development with High Titer and Superior Stability
News Preview
TrueSite TI™, the fourth generation of WuXia™ cell line platform, leverages targeted integration technique to streamline clone screening and guarantees expression stability.The platform has achieved an average mAb titer exceeding 8.0 g/L with over 99% of clonal cell lines maintaining stable protein expression after passaging for 60 generations, w...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US38341P1021
Gossamer Bio Inc
GOSS
LISTED
NASDAQ
Respira Therapeutics Enters into Agreement with Gossamer Bio (Gossamer) Granting Gossamer Option to Acquire Respira from Samsara BioCapital
News Preview
- Transaction designed to accelerate development of RT234 (vardenafil Inhalation powder), an investigational first-in-class, as-needed (PRN) treatment for PAH and PH-ILD -
PALO ALTO, Calif., Sept. 25, 2025 /PRNewswire/ -- Respira Therapeutics, Inc. (Respira or the "Company"), a Samsara BioCapital portfolio company, today announced that it has ent...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: US38341P1021
Gossamer Bio Inc
GOSS
LISTED
NASDAQ
Gossamer Bio Enters into Option Agreement to Acquire Respira Therapeutics and Its Lead Candidate, RT234, an Inhaled, On‑Demand Vardenafil for Pulmonary Hypertension
News Preview
Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced it has entered into an option agreement to acqu...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: US0345691036
Anebulo Pharmaceuticals, Inc.
ANEB
LISTED
NASDAQ
Anebulo Pharmaceuticals Announces First Patients Dosed in Phase 1 Single Ascending Dose Study of Intravenous Selonabant, under Development for Acute Cannabis-Induced Toxicity
News Preview
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid-induced toxicities (the “Company” or “Anebulo”), today announces the first subjects dosed in its Phase 1 single ascending dose (“SAD”) study of intravenous (IV) selonabant in healthy young...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: CA71719L1067
Pharmala Biotech Holdings Inc.
MDMA
LISTED
CSE
PharmAla Partners with Veridion Group as Exclusive Distributor in New Zealand
News Preview
TORONTO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its LaNeo™ MDMA), is pleased to announce that it has signed a distribution agreement with Veridio...
Themefolio
Profiler
Peergroup
© PR Newswire
25.09.2025
ISIN: US00287Y1091
AbbVie Inc
ABBV
LISTED
EURONEXT
QULIPTA® (atogepant) Now Publicly Reimbursed in Quebec for Chronic Migraine and CGRP Class Review Published
News Preview
- Expanded access provides an additional treatment option for those with chronic migraine.- AbbVie is dedicated to people living with this debilitating disease and continues its commitment by providing multiple treatments and programs for these individuals.
MONTREAL, Sept. 25, 2025 /CNW/ - AbbVie (NYSE: ABBV) announced today tha...
Themefolio
Profiler
Peergroup
© Newsfile
25.09.2025
ISIN: CA90429T1003
Unbuzzd Wellness Inc.
UNBZ
LISTED
CSE
Unbuzzd Wellness Raising Up To $5 Million USD Through Reg D 506 (c) Offering; Hosting Live Webinar and Q&A for Interested Accredited Investors on Wednesday, October 1, 2025 at 4:30 PM EST (1:30 PM PST)
News Preview
Vancouver, British Columbia--(Newsfile Corp. - September 25, 2025) - Unbuzzd Wellness Inc. (the "Company" or "Unbuzzd"), the company behind unbuzzdTM ("unbuzzd") — the scientifically-proven and game-changing beverage proven to accelerate alcohol metabolism, restore mental clarity and reduce hangover symptoms — today announced...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US42226A1079
Healthequity Inc
HQY
LISTED
NASDAQ
HealthEquity Strengthens Executive Leadership Team with Strategic Appointments to Drive Growth and Innovation
News Preview
New CMO and Sales Executive Join from Mastercard and EverQuote to Capitalize on Historic HSA Market Expansion New CMO and Sales Executive Join from Mastercard and EverQuote to Capitalize on Historic HSA Market Expansion...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US31447E1055
Femasys Inc
FEMY
LISTED
NASDAQ
Femasys Accelerates European Growth for FemBloc® with Kebomed Partnership
News Preview
-- Femasys leverages Kebomed’s pan-European distribution strength to drive adoption of FemBloc permanent birth control in France and Benelux, unlocking significant market access -- -- Femasys leverages Kebomed’s pan-European distribution strength to drive adoption of FemBloc permanent birth control in France and Benelux, unlocking significant marke...
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: US1101221083
Bristol-Myers Squibb Co
BMY
LISTED
NYSE
Bristol Myers Squibb Builds on Eliquis® (apixaban) Direct-to-Patient Program, Announces New BMS Patient Connect Platform Offering Sotyktu® (deucravacitinib)
News Preview
Bristol Myers Squibb (NYSE: BMY) today announced an expansion of its direct-to-patient offerings, providing eligible U.S. patients with steeply discounted prices for Eliquis® (apixaban) and Sotyktu® (deucravacitinib). Eligible cash-pay patients can now purchase these medicines directly from BMS and significantly lower their out-of-pocket costs....
Themefolio
Profiler
Peergroup
© BusinessWire
25.09.2025
ISIN: US7170811035
Pfizer Inc
PFE
LISTED
NYSE
Pfizer Highlights Momentum in Redefining Standards of Care in Cancer at ESMO 2025
News Preview
Pfizer Inc. (NYSE: PFE) will highlight data across its extensive Oncology portfolio at the European Society for Medical Oncology (ESMO) Congress 2025, being held October 17-21 in Berlin, Germany. Data from more than 45 company-sponsored, investigator-sponsored, and collaborative research abstracts, including 11 oral/mini oral presentations and fiv...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US88165K1016
Tevogen Bio Holdings Inc.
TVGN
LISTED
NASDAQ
Tevogen Marks Major Milestone in Its AI Initiative to Enhance Efficacy of T Cell–Based Therapies with 100x PredicTcell™ Beta Data Expansion
News Preview
WARREN, N.J., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced significant progress in the development of its proprietary PredicTcell™ platform, designed to accelerate precision immunotherapy development and efficacy through advanced machine learning and transformer-based models...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US18914F1030
Clover Health Investments Corp
CLOV
LISTED
NASDAQ
Counterpart Assistant Gets Conversational
News Preview
New generative AI capabilities help physicians prep faster, manage complexity and deliver high-quality value-based care at scale New generative AI capabilities help physicians prep faster, manage complexity and deliver high-quality value-based care at scale...
Themefolio
Profiler
Peergroup
© Newsfile
25.09.2025
ISIN: CA41138T1057
Happy Belly Food Group Inc.
HBFG
LISTED
CSE
Happy Belly Food Group's Smash Burger Brand Rosie's Burgers Secures 1st Real Estate Location in Quebec
News Preview
Toronto, Ontario--(Newsfile Corp. - September 25, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands is pleased to announce that Carma Hospitality has secured a real estate location for their first Quebec-based Rosie's Burgers ("Rosie's") in the nei...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: CA46604F1099
Izotropic Corporation
IZO
LISTED
CSE
AI in Breast Imaging: New BreastCT.com Article Examines IzoView’s Competitive Edge
News Preview
VANCOUVER, British Columbia, and SACRAMENTO, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- via IBN – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic”, or the “Company”), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatmen...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US45826H1095
Integer Holdings Corp
ITGR
LISTED
NYSE
Integer Announces Conference Call to Discuss Third Quarter 2025 Results
News Preview
PLANO, Texas, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) announced today that it will webcast its conference call discussing financial results and business highlights for the third quarter ended Sept. 26, 2025, on Thursday, Oct. 23, 2025, at 8 a.m. CT / 9 a.m. ET. Other forward-looking and material information ma...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: IL0011316309
Mediwound Ltd
MDWD
LISTED
NASDAQ
MediWound Expands Global Reach with Marketing Approval of NexoBrid® in Australia
News Preview
MediWound Expands Global Reach with Marketing Approval of NexoBrid® in Australia...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US14070B3096
Capricor Therapeutics, Inc.
CAPR
LISTED
NASDAQ
Capricor Therapeutics Provides Regulatory Update on Deramiocel Program for Duchenne Muscular Dystrophy Following Type A Meeting
News Preview
SAN DIEGO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today announced a regulatory update for its Biologics License Application (BLA) for Deramiocel, the Company’s investigational cell therapy for the treatment of...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US88688T1007
Tilray Brands Inc
TLRY
LISTED
TSX
Tilray Brands, Inc. to Announce First Quarter Fiscal Year 2026 Financial Results on October 9, 2025
News Preview
NEW YORK and LEAMINGTON, Ontario, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage and wellness industries, today announced that the Company will release its financial results for the first...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: CA01559R1038
Algernon Pharmaceuticals Inc.
AGN
LISTED
CSE
Algernon Announces CAD $4 Million Non-Dilutive Financing to Open Four Brain-Specific PET Scan Clinics in the U.S. for Early Stage Alzheimer’s Detection
News Preview
VANCOUVER, British Columbia, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company announces that it has signed a definitive equipment order and financing agreement with Catalyst MedTech for the provision of four, U.S. FDA cleared O...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: US6551872012
Aclarion, Inc.
ACON
LISTED
NASDAQ
First Patients Enrolled at UHealth – University of Miami in Aclarion’s Pivotal CLARITY Trial
News Preview
First Patients Enrolled at UHealth – University of Miami in Aclarion’s Pivotal CLARITY Trial...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
25.09.2025
ISIN: US5845073056
Medical Care Technologies Inc.
MDCE
LISTED
OTC
Medical Care Technologies Inc. Expands AI Platform to Detect Glaucoma and Cataracts
News Preview
MESA, ARIZONA / ACCESS Newswire / September 25, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) announced that its AI Facial Health Risk Estimator now includes early detection and monitoring of glaucoma and cataracts, two leading causes of vision loss globally.Using high-resolution facial and ocular image analysis, the platform detects:Cornea...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
25.09.2025
ISIN: US47010C4096
Jaguar Health, Inc.
JAGX
LISTED
NASDAQ
Jaguar Health Receives Notice of $250,000 FDA Grant to Fund Confirmatory Trial to Support FDA Approval of Canalevia for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
News Preview
Company strategy: In discussions with multiple potential animal health company partners to expand the indication and commercialize Canalevia for treatment of general diarrhea globally SAN FRANCISCO, CA / ACCESS Newswire / September 25, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar"), under its Jaguar Animal Health tradename for the ve...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
25.09.2025
ISIN: US29350E1047
Enochian Biosciences, Inc
ENOB
LISTED
NASDAQ
Lunai Bioworks Advances Biomarker Discovery Preclinical Program in Parkinson's Disease, Positioning for Strategic Pharma Partnerships
News Preview
NEW YORK CITY, NEW YORK / ACCESS Newswire / September 25, 2025 / Lunai Bioworks Inc. (NASDAQ:RENB), an AI-powered drug discovery company and parent of wholly owned subsidiary BioSymetrics, today announced advancement of its biomarker discovery preclinical program in Parkinson's Disease. The initiative leverages BioSymetrics' proprietary Augusta Pla...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: FR0000032526
Guerbet SA
GBT
LISTED
EURONEXT
GUERBET : Mise à disposition du rapport financier semestriel 2025
News Preview
...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: CH0011432447
Basilea Pharmaceutica AG Allschwil
BSLN
LISTED
SIX
Basilea awarded BARDA contract for the development of novel oral phase 3-ready antibiotic ceftibuten-ledaborbactam
News Preview
- Total non-dilutive funding of up to USD 159 million upon completion of predefined milestones, including near-term committed funding of USD 6 million...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.09.2025
ISIN: BE0003874915
Fagron NV
FAGR
LISTED
EURONEXT
Fagron announces the acquisition of UCP in North America and FDA inspection update
News Preview
Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 25 September 2025 – 7:00 AM CET...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
